TEYSUNO (TEGAFUR/GIMERACIL/OTERACIL) CAPSULES

The combination drug tegafur/gimeracil/oteracil (trade name Teysuno, and TS-1 in Japan), also known as S-1, is used for the treatment of advanced gastric cancer. It is labelled for use in combination with cisplatin in many European countries, and for head and neck cancer, colorectal cancer, non–small-cell lung, breast, pancreatic, and biliary tract cancers in several countries in Asia.

It is also being developed for the treatment of hepatocellular carcinoma and has activity in esophageal, breast, cervical, and colorectal cancer.

Teysuno (tegafur/gimeracil/oteracil) capsules
suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

SOURCING:

ALLEVIARE LIFE SCIENCES connects the buyer with the supplier who can ship Teysuno (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Teysuno is manufactured by Taiho Pharmaceutical Co., Ltd and Nordic Group BV

ALLEVIARE LIFE SCIENCES provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for Teysuno (tegafur/gimeracil/oteracil) capsules will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Teysuno is a medicine that contains the active substances tegafur, gimeracil and oteracil. It is available as capsules containing 15 mg tegafur with 4.35 mg gimeracil and 11.8 mg oteracil, and as capsules containing 20 mg tegafur with 5.8 mg gimeracil and 15.8 mg oteracil.

Teysuno is used to treat adults with advanced gastric (stomach) cancer. It is used in combination with cisplatin (another anticancer medicine). The medicine can only be obtained with a prescription.

Medicine Name: Teysuno
Generic Name: tegafur/gimeracil/oteracil
Approval Date: 03/14/2011
Company Name: Taiho Pharmaceutical Co., Ltd and Nordic Group BV
Available as (Form & Strength): For injectable suspension: lyophilized powder containing 100 mg of paclitaxel formulated as albumin-bound particles in the single-use vial for reconstitution.